Skip to main content

Table 8 Difference in means between treatment and control groups for HDL at final follow-up

From: Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review

Author Sample size (treatment group vs. control group) Difference 95% CI
Cabral et al. [57] 32 (14 vs. 18) 0.26 mmol/L* − 0.17 to 0.70
Caraccio et al. [58] 49 (24 vs. 25) − 0.10 mmol/L* − 0.27 to 0.07
Duman et al. [60] 39 (20 vs. 19) 0.004 mmol/L* − 0.45 to 0.44
Iqbal et al. [62] 64 (32 vs. 32) 0.00 mmol/L* − 0.22 to 0.22
Liu et al. [64] 119 (60 vs. 59) 0.03 mmol/L** − 0.03 to 0.09
Mikhail et al. [66] 120 (60 vs. 60) 0.09 mmol/L* − 0.01 to 0.20
Monzani et al. [68] 45 (23 vs. 22) − 0.17 mmol/L* − 0.49 to 0.14
Nagasaki et al. [69] 95 (48 vs. 47) 0.02 mmol/L** − 0.12 to 0.16
Teixeira et al. [74, 75] 26 (11 vs. 15) 0.35 mmol/L* − 0.29 to 0.99
  1. *Value is the difference in mean scores at final follow-up between treatment and control groups
  2. **Value is the difference in mean variation scores from baseline to follow-up between treatment and control group